| Product Name | MF | CAS | Details |
|---|
| CYT296 | C18H16O2S | 1799392-31-6 | Details |
| Nrf2-IN-3 | C22H26N4O4S | 6325-13-9 | Details |
| (RS)-K20 | 2915618-92-5 | Details |
| Propargyl-PEG4-GGFG-DXd | C54H63FN8O15 | 2762518-94-3 | Details |
| CHI-000-667 | C21H16ClNO4S | 905794-70-9 | Details |
| MiTMAB | C17H38BrN | 2253617-91-1 | Details |
| Cyclotheonellazole A | 2094993-48-1 | Details |
| XMT-1519 conjugate-1 | C101H149N23O42 | 2720500-19-4 | Details |
| Targeting the bacterial sliding clamp peptide 46 | 2756997-82-5 | Details |
| PBR28 | C21H20N2O3 | 253307-65-2 | Details |
| rel-(2S,3R)-Voruciclib hydrochloride | 1253647-46-9 | Details |
| Nurr1 agonist 4 | C12H10O4 | 87645-58-7 | Details |
| HP210 | C22H19N3O2S2 | 728039-52-9 | Details |
| Necrocide 1 | C23H27NO3 | 1247028-61-0 | Details |
| GPR52 receptor modulator 1 | C19H14F4N4O | 2642079-89-6 | Details |
| ZINC00784494 | C20H14N2O3S | 317328-17-9 | Details |
| CCT374705 | C21H18ClF3N4O2 | 2640647-90-9 | Details |
| JAK-IN-26 | C22H24N6O3 | 2417134-93-9 | Details |
| β-catenin-IN-6 | C22H19ClN6O | 1039731-99-1 | Details |
| KRAS G12D mutation regulator 4 | C33H33FN6O2 | 2621927-57-7 | Details |
| Val-Ala-PAB-MMAE | C55H88N8O11 | 1912408-92-4 | Details |
| D1R antagonist 1 | 2983777-67-7 | Details |
| HDAC-IN-59 | 2944459-43-0 | Details |
| P2X3-IN-1 | 2823331-49-1 | Details |
| (1R,4S)-Yimitasvir diphosphate | 2734870-15-4 | Details |
| HDAC-IN-60 | 2944459-58-7 | Details |
| VU0364739 | C26H27FN4O2 | 1244639-78-8 | Details |
| Antifungal agent 50 | C25H20ClN5O2S | 2896209-33-7 | Details |
| SN38-COOH | C26H24N2O8 | 2170118-23-5 | Details |
| MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan | C54H58FN9O13 | 2414254-41-2 | Details |
| Urease-IN-6 | C18H19N3OS | 362502-79-2 | Details |
| SC239 | C65H84N10O11 | 1977557-97-3 | Details |
| FLT3-IN-19 | C22H26N8O | 2237234-48-7 | Details |
| TAM558 | C79H122N14O19S | 1802499-21-3 | Details |
| Mal-EGGGG-PEG8-amide-bis(deoxyglucitol) | C55H94N10O31 | 2360920-01-8 | Details |
| UZH1b | C32H42N6O3 | 2814392-17-9 | Details |
| Clezutoclax | C83H102N12O24S2 | 1949843-71-3 | Details |
| JG-23 | C19H16ClN3OS2 | 2640819-75-4 | Details |
| Fosnetupitant chloride monohydrochloride | C31H36F6N4O5P. HCl. Cl | 1643757-72-5 | Details |
| I-287 | C30H30ClFN4O4 | 2014368-93-3 | Details |
| JT002 | 2238820-43-2 | Details |
| Val-Ala-PABC-Exatecan | 2845164-91-0 | Details |
| α-Glucosidase-IN-28 | 2949513-10-2 | Details |
| NH2-c[X-R-L-S-X]-K-G-P-(D-2Nal) | 2891469-81-9 | Details |
| IDO1/TDO-IN-6 | 2948772-71-0 | Details |
| PPARδ agonist 9 | C26H28ClF3N4O3S | 928023-21-6 | Details |
| Azilsartan mepixetil potassium | C36H34N6O8.K | 2153458-32-1 | Details |
| DprE1-IN-9 | 2906099-98-5 | Details |
| (Aminooxy)acetamide-Val-Cit-PAB-MMAE | C60H97N11O14 | 2446645-88-9 | Details |
| NH2-methylpropanamide-Exatecan TFA | C28H29FN4O5.C2HF3O2 | 1817857-35-4 | Details |
| NH2-c[X-R-L-S-X]-K-G-P-(D-1Nal) | 2891469-80-8 | Details |
| Neurotensin(8-13) 3TFA(60482-95-3(free base)) | 2952825-79-3 | Details |
| Salvianan A | C20H17NO2 | 2162956-63-8 | Details |
| BIM-23056 TFA | 1426173-61-6 | Details |
| 2-Furoyl-LIGRLO-amide TFA | 2468029-34-5 | Details |
| Obestatin(rat) TFA | 1312186-27-8 | Details |
| Hemopressin(rat) TFA | 1431329-47-3 | Details |
| Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan | C57H65FN10O15 | 1599439-54-9 | Details |
| Colletofragarone A2 | C22H26O6 | 181377-06-0 | Details |
| Koshidacin B | 2925302-01-6 | Details |
| Eucalyptacid A | 2940889-52-9 | Details |
| Ac-Val-Gln-aIle-Val-aTyr-Lys-NH2 | 2858785-68-7 | Details |
| Osivelotor | C20H22N2O6 | 2417955-18-9 | Details |
| NK3R-IN-1 | 2854331-14-7 | Details |
| QR-0217 | C19H13NO3 | 1027786-12-4 | Details |
| PI5P4Kα-IN-1 | C20H17N3O2S | 2428737-31-7 | Details |
| WH-10417-099 | C52H62N8O13S | 2769753-42-4 | Details |
| KRAS G12C mutant protein inhibitor A-1 | C31H26ClF4N7O2 | 2658538-04-4 | Details |
| Glucocerebrosidase-IN-1 hydrochloride | 2279945-77-4 | Details |
| Antitumor agent-97 | C24H34O3 | 2654024-16-3 | Details |
| MAO-IN-3 | 797805-26-6 | Details |
| COX-2-IN-30 | 1160498-08-7 | Details |
| SHP2-IN-22 | 2802453-88-7 | Details |
| Ferric nitrilotriacetate | C6H6FeNO6 | 16448-54-7 | Details |
| Farletuzumab ecteribulin | 2407465-18-1 | Details |
| MKA031 | 2951012-00-1 | Details |
| p-fin4 | 2883747-74-6 | Details |
| vc-PABC-DM1 | C53H75ClN8O13S | 1416792-90-9 | Details |
| GGFG-amide-glycol-amide-Exatecan | C43H47FN8O11 | 2866301-18-8 | Details |
| Antifungal agent 49 | C15H12O4 | 1414861-21-4 | Details |
| (S,R)-CFT8634 | C37H45F3N6O5 | 2704617-95-6 | Details |
| FHND5071 | 2761152-16-1 | Details |
| Mc-Alanyl-Alanyl-Asparagine-PAB-MMAE | C67H101N11O16 | 1638970-46-3 | Details |
| Antifungal agent 48 | C13H10O4S | 2142003-75-4 | Details |
| Mal-PEG8-Val-Ala-PAB-Exatecan | C66H85FN8O20 | 2679821-39-5 | Details |
| MEL24 | C17H18N4O3 | 642072-48-8 | Details |
| PRMT5-IN-29 | C18H19Cl2N5O5.ClH | 2242788-69-6 | Details |
| Glucocorticoid receptor agonist-2 Ala-Ala-Mal | C47H50F2N4O12 | 2166376-64-1 | Details |
| PD-L1-IN-2 | C33H38N4O6 | 2894733-91-4 | Details |
| H3B-968 | C22H18F6N4O4S | 2912294-90-5 | Details |
| Maytansinoid B | C36H51ClN4O10 | 1628543-40-7 | Details |
| NaPi2b-IN-2 | C41H47ClF3N5O5S | 2227445-31-8 | Details |
| MethylCBI-azaindole-benzamide-MOM-Boc-ethylenediamine-D | C44H51ClN6O10 | 2222445-87-4 | Details |
| Mps1-IN-6 (Compound 9) | C24H27N7O2 | 2489220-49-5 | Details |
| ZL-2201 | 2865115-39-3 | Details |
| DNA Gyrase-IN-8 | 2925308-76-3 | Details |
| α-Glucosidase-IN-29 | 2949513-11-3 | Details |
| NSC 288387 | C19H16N4O3 | 61369-43-5 | Details |
| INX-SM-6 | C32H36N2O6S | 2734878-16-9 | Details |
| (R)-Necrocide 1 | C23H27NO3 | 1247028-62-1 | Details |
| Product Total： Product Page： | ||||
| 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 | ||||